The measure authorizes the state to sell $3 billion in general obligation bonds to provide funding for stem cell research and research facilities in California . A new state medical research institute would be established to use the bond funds to award grants and loans for stem cell research and research facilities, and to manage stem cell research activities funded by this measure within California.